Weigao Group Announces Overseas Regulatory Filing for Orthopaedic Subsidiary

Bulletin Express

Aug 25

Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.

The company disclosed that Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange’s website (http://www.sse.com.cn/home/search/?webswd=688161). The Hong Kong filing serves to mirror that disclosure for international investors and ensure alignment with cross-border reporting requirements.

The statement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.

Corporate governance details were also provided: the Weigao Group Board currently comprises four Executive Directors (Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming), two Non-executive Directors (Chen Lin, Tang Zhengpeng) and four Independent Non-executive Directors (Li Guohui, Meng Hong, Li Qiang, Sun Heng).

The announcement was authorised by Chairman Long Jing and dated 25 August 2026 in Weihai, Shandong, PRC.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1135249647"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135249647\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135249647?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-25 22:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135249647","market":"us","top_or_hot":-1,"title":"Weigao Group Announces Overseas Regulatory Filing for Orthopaedic Subsidiary","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.</p>\n<p>The company disclosed that Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange’s website (http://www.sse.com.cn/home/search/?webswd=688161). The Hong Kong filing serves to mirror that disclosure for international investors and ensure alignment with cross-border reporting requirements.</p>\n<p>The statement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.</p>\n<p>Corporate governance details were also provided: the Weigao Group Board currently comprises four Executive Directors (Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming), two Non-executive Directors (Chen Lin, Tang Zhengpeng) and four Independent Non-executive Directors (Li Guohui, Meng Hong, Li Qiang, Sun Heng).</p>\n<p>The announcement was authorised by Chairman Long Jing and dated 25 August 2026 in Weihai, Shandong, PRC.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group Announces Overseas Regulatory Filing for Orthopaedic Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group Announces Overseas Regulatory Filing for Orthopaedic Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-25 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.</p>\n<p>The company disclosed that Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange’s website (http://www.sse.com.cn/home/search/?webswd=688161). The Hong Kong filing serves to mirror that disclosure for international investors and ensure alignment with cross-border reporting requirements.</p>\n<p>The statement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.</p>\n<p>Corporate governance details were also provided: the Weigao Group Board currently comprises four Executive Directors (Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming), two Non-executive Directors (Chen Lin, Tang Zhengpeng) and four Independent Non-executive Directors (Li Guohui, Meng Hong, Li Qiang, Sun Heng).</p>\n<p>The announcement was authorised by Chairman Long Jing and dated 25 August 2026 in Weihai, Shandong, PRC.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1135249647","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135249647","pubTimestamp":1787669237,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团宣布骨科子公司海外监管备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.\nThe company disclosed that Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange’s website (http://www.sse.com.cn/home/search/?webswd=688161). The Hong Kong filing serves to mirror that disclosure for international investors and ensure alignment with cross-border reporting requirements.\nThe statement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.\nCorporate governance details were also provided: the Weigao Group Board currently comprises four Executive Directors (Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming), two Non-executive Directors (Chen Lin, Tang Zhengpeng) and four Independent Non-executive Directors (Li Guohui, Meng Hong, Li Qiang, Sun Heng).\nThe announcement was authorised by Chairman Long Jing and dated 25 August 2026 in Weihai, Shandong, PRC.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"policyRegulatory,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}